These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3857158)

  • 1. Aminoglycoside treatment and renal prostaglandin excretion in premature infants.
    Kühl PG; Soeding K; Seyberth HW
    Dev Pharmacol Ther; 1985; 8(1):61-7. PubMed ID: 3857158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion rates of 6-keto-PGF1 alpha in preterm infants recovering from respiratory distress with and without patent ductus arteriosus.
    Seyberth HW; Müller H; Ulmer HE; Wille L
    Pediatr Res; 1984 Jun; 18(6):520-4. PubMed ID: 6588360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric determination of urinary prostaglandins in preterm infants. The basis for an effective and safe therapeutic regimen for the pharmacological closure.
    Seyberth HW; Müller H; Erlenmaier T; Mrongovius R
    Eur J Clin Pharmacol; 1980 Jul; 18(1):89-93. PubMed ID: 7398753
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma prostaglandin E2 and F2 alpha in preterm infants: association with respiratory distress syndrome and patent ductus arteriosus.
    Kopelman AE; Dombroski D; Engelke SC; Louis TM
    Prostaglandins Leukot Med; 1983 Apr; 10(4):423-31. PubMed ID: 6574525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin levels: predictors of indomethacin responsiveness.
    Hammerman C; Zaia W; Berger S; Strates E; Aldousany A
    Pediatr Cardiol; 1986; 7(2):61-5. PubMed ID: 3467304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus.
    Lin YJ; Tsai YJ; Chen JS; Lin JS; Wu JM; Lin CH; Yeh TF
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):104-7. PubMed ID: 7793274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus.
    Li Y; Zelenina M; Plat-Willson G; Marcoux MO; Aperia A; Casper C
    Acta Paediatr; 2011 Jan; 100(1):59-66. PubMed ID: 21143292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
    Zambraski EJ; Dodelson R; Guidotti SM; Harnett CA
    Med Sci Sports Exerc; 1986 Dec; 18(6):678-84. PubMed ID: 3537627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible indomethacin-aminoglycoside interaction in preterm infants.
    Zarfin Y; Koren G; Maresky D; Perlman M; MacLeod S
    J Pediatr; 1985 Mar; 106(3):511-3. PubMed ID: 3973790
    [No Abstract]   [Full Text] [Related]  

  • 11. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
    Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
    Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous indomethacin and changes of renal function in premature infants with patent ductus arteriosus.
    John EG; Vasan U; Hastreiter AR; Bhat R; Evans MA
    Pediatr Pharmacol (New York); 1984; 4(1):11-9. PubMed ID: 6739182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma-prostaglandins in pre-term neonates before and after treatment for patient ductus arteriosus.
    Lucas A; Mitchell MD
    Lancet; 1978 Jul; 2(8081):130-2. PubMed ID: 78327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus.
    Friedman WF; Printz MP; Kirkpatrick SE
    Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580
    [No Abstract]   [Full Text] [Related]  

  • 16. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.
    Seyberth HW; Knapp G; Wolf D; Ulmer HE
    Eur J Pediatr; 1983 Dec; 141(2):71-6. PubMed ID: 6363085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus.
    Seyberth HW; Rascher W; Hackenthal R; Wille L
    J Pediatr; 1983 Dec; 103(6):979-84. PubMed ID: 6358443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New aspects on the pathogenesis of patent ductus arteriosus in premature infants].
    Seyberth HW
    Monatsschr Kinderheilkd; 1986 Jul; 134(7):423-35. PubMed ID: 3528823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.